2-(4-phenoxyphenyl)-7-(1-(3-(4-(3-carbamoyl-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl)-3-oxopropyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
Zanubrutinib Impurity 2 (Racemic mixture) is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Zanubrutinib Impurity 2 (Racemic mixture) for method validation Zanubrutinib Impurity 2 (Racemic mixture) reference standard Zanubrutinib Impurity 2 (Racemic mixture) for ANDA filing Zanubrutinib Impurity 2 (Racemic mixture) for forced degradation studies Zanubrutinib Impurity 2 (Racemic mixture) identification standard Zanubrutinib Impurity 2 (Racemic mixture) for DMF filing Zanubrutinib Impurity 2 (Racemic mixture) HPLC standard Zanubrutinib Impurity 2 (Racemic mixture) supplier Zanubrutinib Impurity 2 (Racemic mixture) manufacturer Zanubrutinib Impurity 2 (Racemic mixture) distributor
